Search clinical trials for: 2nd generation ADT (abiraterone or enzalutamide)
Total 300 results
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.Active, not recruiting
-
Qian QinJanssen, LP; UT Southwestern Comprehensive Cancer CenterNot yet recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | BRIP1 Gene Mutation | PALB2 Gene Mutation | CHEK2 Gene Mutation | FANCA Gene Mutation | RAD51B Gene Mutation | RAD54L Gene Mutation | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Deleterious HRR Gene Mutation
-
University of Maryland, BaltimoreJanssen Scientific Affairs, LLCRecruitingProstate Cancer | Oligometastatic DiseaseUnited States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingNeoadjuvant Therapy | High Risk Prostate Cancer | Locally Advanced Prostate Cancer | Intense Endocrine TherapyChina
-
James J. Peters Veterans Affairs Medical CenterNot yet recruitingMetastatic Cancer | Neoplasm, ProstateUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Active, not recruitingProstate CancerUnited States
-
VA Office of Research and DevelopmentRecruitingRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Oligometastasis | Oligorecurrence | De Novo Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstate Cancer MetastaticCanada, Germany, United States, Israel, Puerto Rico, Taiwan, Korea, Republic of, Australia, Chile, China, France, Norway, Czechia, Finland, Hong Kong, Netherlands, Poland, Spain, Sweden, Turkey, Denmark, Hungary, Italy, United Kingdom, ... and more
-
University of HawaiiTerminated
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Astellas Pharma Global Development, Inc.PfizerRecruitingProstate CancerUnited States, Korea, Republic of, Japan, Belgium, Spain, Argentina, Australia, Canada, Chile, Czechia, Denmark, Finland, France, Georgia, Germany, Israel, Italy, Moldova, Republic of, New Zealand, Poland, Russian Federation, Slov... and more
-
University of MichiganNational Cancer Institute (NCI); US Department of Veterans AffairsRecruiting
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsCanada, France, Poland, Ukraine, United Kingdom, China, Belgium, Spain, Argentina, Colombia, Israel, Mexico, Portugal, Bulgaria, Germany, Malaysia, Romania, South Africa, Turkey, Korea, Republic of, Japan, Australia, Netherlands, Sweden, New Zealand and more
-
University of SydneyNational Health and Medical Research Council, Australia; European Organisation... and other collaboratorsActive, not recruitingProstatic NeoplasmsUnited States, Australia, United Kingdom, Spain, New Zealand, Ireland, Austria, Belgium, Slovenia
-
SanofiCompletedProstate Cancer MetastaticUnited Kingdom, Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain
-
National Cancer Institute (NCI)Active, not recruitingCastrate Sensitive Prostate CancerUnited States
-
Epizyme, Inc.Active, not recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Spain, Belgium
-
International Antiviral Therapy Evaluation CenterGilead SciencesCompleted
-
Paul Mathew, MDHoosier Cancer Research Network; Tesaro, Inc.TerminatedMetastatic Prostate CancerUnited States
-
SanofiTerminated
-
University of Michigan Rogel Cancer CenterRecruitingProstate Cancer | Oligometastatic Disease | Castrate Sensitive Prostate CancerUnited States
-
Astellas Pharma IncCompletedMetastatic Castration Resistant Prostate CancerIndia
-
Astellas Pharma China, Inc.Active, not recruitingMetastatic Hormone Sensitive Prostate CancerChina
-
Instituto do Cancer do Estado de São PauloJanssen, LPCompleted
-
MedSIRPfizerActive, not recruitingMetastatic Prostate CancerSpain
-
Merus N.V.RecruitingMetastatic Castration-resistant Prostate Cancer | NSCLC Harboring NRG1 FusionUnited States
-
BayerCompleted
-
Kenneth Pienta, MDProstate Cancer Foundation NorwayWithdrawnProstate Cancer | Localized Prostate CancerUnited States
-
Icahn School of Medicine at Mount SinaiSanofi; BayerCompletedProstate CancerUnited States
-
Nuvation Bio Inc.RecruitingBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Breast Carcinoma | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Advanced Solid Tumor | Cancer of the Ovary | Pancreas Cancer | Triple-negative Breast Cancer | Cancer of Pancreas | Pancreas Neoplasm | Prostate Neoplasm | Cancer... and other conditionsUnited States, Australia
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
Medical University of ViennaLund University; Ziekenhuis Netwerk Antwerpen (ZNA); St. Antonius Hospital; Azienda... and other collaboratorsNot yet recruitingProstate Cancer | Prostate Cancer Metastatic | Oligometastasis | Prostate Neoplasm | Oligometastatic Disease | Prostate Cancer Metastatic to Bone
-
University of Texas Southwestern Medical CenterNational Institute on Aging (NIA)CompletedVentricular FunctionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
ExelixisTakeda; Roche-GenentechActive, not recruitingMetastatic Prostate Cancer | Prostate AdenocarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Russian Federation, Singapore, Spain, ... and more
-
AstraZenecaRecruitingMetastatic Castration-Sensitive Prostate CancerUnited States, Canada, Spain, United Kingdom, Italy, Australia, Korea, Republic of, Belgium, Germany, Japan, Peru, France, China, India, Taiwan, Thailand, Austria, Brazil, Turkey, Malaysia, Finland, Netherlands, Chile, Hungary, Poland, Sw...
-
University of MiamiMedline IndustriesActive, not recruiting
-
Merck Sharp & Dohme LLCCompletedProstatic NeoplasmsUnited States, Argentina, Australia, Austria, Brazil, Canada, Chile, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom, New Zealand
-
AstraZenecaBayerRecruitingMetastatic Prostate CancerItaly, United Kingdom, Australia, United States
-
Boehringer IngelheimCompleted
-
VA Office of Research and DevelopmentCompletedNewly Diagnosed Oligometastatic Prostate CancerUnited States
-
Shiga UniversityOsaka University; Kanazawa Medical University; Nagahama Red Cross Hospital; Nagahama... and other collaboratorsUnknownType 2 Diabetes MellitusJapan
-
Tian XieLinkDoc Technology (Beijing) Co. Ltd.RecruitingAdenocarcinoma | Carcinoma | Non-Small-Cell Lung CancerChina
-
Janssen Research & Development, LLCCompleted
-
Drugs for Neglected DiseasesUNITAID; French Development AgencyCompletedHIVUganda, Kenya, Tanzania
-
Latin American Cooperative Oncology GroupJanssen PharmaceuticalsCompleted
-
Merck Sharp & Dohme LLCActive, not recruitingProstatic NeoplasmsUnited States, Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom, Bulgaria, Czechia, Hu... and more
-
Tianjin Anding HospitalRecruitingHealthy | Anxiety DisorderChina
-
Rahul AggarwalFortis Therapeutics, Inc.RecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States